Loading
VI
Vivus Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Amos John P., was filed 04 Mar 2019.
Vivus Inc: what insiders have been doing
Vivus Inc is a listed company. Filings by its managers are published through SEC (Form 4). No insider at Vivus Inc has published a filing in the past twelve months. The most recent one dates from 18 November 2019.
Our records for Vivus Inc go back to 2016, with 17 purchases and 58 sales on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
279
Thresholds
n/a
Buy Volume
€2M
17 ops. · all time
Sell Volume
€3M
58 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 18 November 2019
Declarations279 total
700 shares@ US$2.3830.5% of flowCommon StockSEC:0001123292-19-001281:0
700 shares@ US$2.383.7% of flowCommon StockSEC:0001123292-19-001282:0
700 shares@ US$2.8435.0% of flowCommon StockSEC:0001123292-19-000772:0
700 shares@ US$2.844.4% of flowCommon StockSEC:0001123292-19-000774:0
11,000 shares@ US$4.855.1% of flowCommon StockSEC:0001123292-19-000414:0
Canonical exit: 30 May 2019 (T+90)
8,500 shares@ US$4.8295.1% of flowCommon StockSEC:0001123292-19-000416:0
Canonical exit: 29 May 2019 (T+90)
700 shares@ US$2.7129.0% of flowCommon StockSEC:0001123292-18-001067:0
700 shares@ US$2.714.1% of flowCommon StockSEC:0001123292-18-001066:0
10,000 shares@ US$4.0787.8% of flowCommon StockSEC:0001123292-18-001056:0
Canonical exit: 4 Feb 2019 (T+90)
139 sharesCommon StockSEC:0001123292-18-000995:0
139 sharesCommon StockSEC:0001123292-18-000997:0
43 shares@ US$5.630.5% of flowCommon StockSEC:0001123292-18-000995:1
43 shares@ US$5.634.1% of flowCommon StockSEC:0001123292-18-000997:1
1,389 sharesCommon StockSEC:0001123292-18-000935:0
1,389 sharesCommon StockSEC:0001123292-18-000933:0
438 shares@ US$0.634.5% of flowCommon StockSEC:0001123292-18-000935:1
438 shares@ US$0.630.6% of flowCommon StockSEC:0001123292-18-000933:1
1,389 sharesCommon StockSEC:0001123292-18-000863:0
1,389 sharesCommon StockSEC:0001123292-18-000865:0
439 shares@ US$0.772.9% of flowCommon StockSEC:0001123292-18-000863:1
439 shares@ US$0.770.6% of flowCommon StockSEC:0001123292-18-000865:1
25,000 shares@ US$0.707.5% of flowCommon StockSEC:0001123292-18-000848:0
1,389 sharesCommon StockSEC:0001123292-18-000821:0
1,389 sharesCommon StockSEC:0001123292-18-000823:0
438 shares@ US$0.840.6% of flowCommon StockSEC:0001123292-18-000821:1
25 of 279 declarations
About Vivus Inc
Vivus Inc is a biopharmaceutical company focused on developing treatments for sexual health disorders and obesity. It is listed on NASDAQ under the symbol VVUS.
